Healthcare >> CEO Interviews >> October 17, 2003
MARK A. STEEDMAN is currently the Director of Business Development for
Interface Biologics and is responsible for new business and current
operations of the company. He has over 7 years direct experience in
business development and managing client relationships. Prior to joining
Interface, Mr. Steedman worked for Schaeffers Consulting Engineers in
Toronto developing new business initiatives for the company. Mr.
Steedman holds degrees in Biology and Engineering from Queen's
University, Kingston, Canada and a MBA from Wilfred Laurier University,
Waterloo, Canada. Profile
Mr. Steedman: Interface Biologics is a therapeutic biomaterials company
focused on developing the next generation of
